WO2002040455A8 - Substituierte amidoalkyluracile und ihre verwendung als inhibitoren der poly (adp-ribose)-synthetase (pars) - Google Patents
Substituierte amidoalkyluracile und ihre verwendung als inhibitoren der poly (adp-ribose)-synthetase (pars)Info
- Publication number
- WO2002040455A8 WO2002040455A8 PCT/EP2001/012694 EP0112694W WO0240455A8 WO 2002040455 A8 WO2002040455 A8 WO 2002040455A8 EP 0112694 W EP0112694 W EP 0112694W WO 0240455 A8 WO0240455 A8 WO 0240455A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- uracils
- pars
- adp
- synthetase
- ribose
- Prior art date
Links
- -1 poly(adp-ribose) Polymers 0.000 title 3
- 102000003960 Ligases Human genes 0.000 title 1
- 108090000364 Ligases Proteins 0.000 title 1
- 108091026813 Poly(ADPribose) Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical class O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
- C07D239/96—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/416,622 US7125995B2 (en) | 2000-11-14 | 2001-11-02 | Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (PARS) |
AU2002224825A AU2002224825A1 (en) | 2000-11-14 | 2001-11-02 | Substituted amidoalkyl uracils and the use thereof |
EP01994632A EP1339699A1 (de) | 2000-11-14 | 2001-11-02 | Substituierte amidoalkyluracile und ihre verwendung als inhibitoren der poly (adp-ribose)-synthetase (pars) |
CA002428335A CA2428335A1 (en) | 2000-11-14 | 2001-11-02 | Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (pars) |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10056312.0 | 2000-11-14 | ||
DE10056312A DE10056312A1 (de) | 2000-11-14 | 2000-11-14 | Substituierte Amidoalkyluracile und ihre Verwendung |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002040455A1 WO2002040455A1 (de) | 2002-05-23 |
WO2002040455A8 true WO2002040455A8 (de) | 2002-07-18 |
Family
ID=7663202
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2001/012694 WO2002040455A1 (de) | 2000-11-14 | 2001-11-02 | Substituierte amidoalkyluracile und ihre verwendung als inhibitoren der poly (adp-ribose)-synthetase (pars) |
Country Status (6)
Country | Link |
---|---|
US (1) | US7125995B2 (de) |
EP (1) | EP1339699A1 (de) |
AU (1) | AU2002224825A1 (de) |
CA (1) | CA2428335A1 (de) |
DE (1) | DE10056312A1 (de) |
WO (1) | WO2002040455A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7615556B2 (en) | 2006-01-27 | 2009-11-10 | Bristol-Myers Squibb Company | Piperazinyl derivatives as modulators of chemokine receptor activity |
JP5730281B2 (ja) * | 2009-03-27 | 2015-06-10 | 武田薬品工業株式会社 | ポリ(adp−リボース)ポリメラーゼ(parp)阻害剤 |
EP2731942B1 (de) | 2011-07-13 | 2015-09-23 | Novartis AG | Neue 2-piperidin-1-yl-acetamidverbindungen zur verwendung als tankyrase-hemmer |
AP2014007400A0 (en) | 2011-07-13 | 2014-01-31 | Novartis Ag | 4-Piperidinyl compounds for use as tankyrase inhibitors |
US9227982B2 (en) | 2011-07-13 | 2016-01-05 | Novartis Ag | 4-oxo-3,5,7,8-tetrahydro-4H-pyrano[4,3-d]pyrminidinyl compounds for use as tankyrase inhibitors |
CN104066723B (zh) * | 2011-11-01 | 2016-06-29 | 南京英派药业有限公司 | 1-(芳基甲基)-5,6,7,8-四氢喹唑啉-2,4-二酮和相关化合物及其应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1959705A1 (de) | 1969-11-28 | 1971-06-03 | Bayer Ag | Verfahren zur Herstellung von Uracilderivaten |
DE2126148A1 (en) | 1971-05-26 | 1972-12-07 | Farbenfabriken Bayer Ag, 5090 Leverkusen | Prepn of uracil derivs - useful as plant - protection agents and their inters |
DE2142317A1 (de) | 1971-08-24 | 1973-03-01 | Bayer Ag | Hypnotisches mittel |
JP2860689B2 (ja) | 1990-03-14 | 1999-02-24 | 第一製薬株式会社 | ピリミジン誘導体 |
US5185446A (en) | 1990-09-04 | 1993-02-09 | Neurogen Corporation | Certain cycloalkyl imidazopyrimidines; a new class of gaba brainreceptor ligands |
US5859014A (en) | 1995-06-09 | 1999-01-12 | Syntex (U.S.A.) Inc. | Pyrimidinedione, pyrimidinetrione, triazinedione and tetrahydroquinazolinedione derivatives as α1 -adrenergic receptor antagonists |
GB9513508D0 (en) * | 1995-07-03 | 1995-09-06 | Fujisawa Pharmaceutical Co | Quinazoline derivatives |
AU2004200A (en) | 1999-01-14 | 2000-08-01 | Meiji Seika Kaisha Ltd. | Poly(adp-ribose) polymerase inhibitors consisting of pyrimidine derivatives |
-
2000
- 2000-11-14 DE DE10056312A patent/DE10056312A1/de not_active Withdrawn
-
2001
- 2001-11-02 WO PCT/EP2001/012694 patent/WO2002040455A1/de not_active Application Discontinuation
- 2001-11-02 CA CA002428335A patent/CA2428335A1/en not_active Abandoned
- 2001-11-02 EP EP01994632A patent/EP1339699A1/de not_active Withdrawn
- 2001-11-02 US US10/416,622 patent/US7125995B2/en not_active Expired - Fee Related
- 2001-11-02 AU AU2002224825A patent/AU2002224825A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002040455A1 (de) | 2002-05-23 |
CA2428335A1 (en) | 2002-05-23 |
US7125995B2 (en) | 2006-10-24 |
US20050075347A1 (en) | 2005-04-07 |
AU2002224825A1 (en) | 2002-05-27 |
EP1339699A1 (de) | 2003-09-03 |
DE10056312A1 (de) | 2002-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA03010810A (es) | Pirimidinas inhibidoras de cdk, su obtencion y su uso como medicamentos. | |
WO2004055010A3 (en) | Cyclopropyl compounds as ccr5 antagonists | |
WO2006005609A3 (de) | Substituierte oxindol-derivate und diese enthaltende arzneimittel | |
WO2004054581A3 (en) | Cyclohexyl compounds as ccr5 antagonists | |
WO2004054974A3 (en) | Piperidine derivatives as ccr5 antagonists | |
SI1441734T1 (sl) | Dihidropirimidin karboksamidni inhibitorji HIV-integraze | |
DE60322423D1 (de) | Pyrrolidin- und azetidinverbindungen alsccr5-antagonisten | |
JO2311B1 (en) | Alkyl inhibitors Ariel phosphodiesterase-4 | |
WO2003000695A8 (en) | Pyrrolopyrimidines as protein kinase inhibitors | |
MY141661A (en) | 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
WO2005028479A3 (en) | Hiv replication inhibiting purine derivatives | |
WO2001066534A3 (en) | Cyclic and bicyclic diamino histamine-3 receptor antagonists | |
AU2003300911A1 (en) | Heterocyclic compounds as ccr5 antagonists | |
WO2003002064A3 (en) | Fused pyrimidine dhfr inhibitors as antibacterials | |
MXPA03010761A (es) | Combinaciones farmaceuticas. | |
MXPA03005601A (es) | Nuevos compuestos y composiciones como inhibidores de catepsina. | |
RS20060280A (en) | Novel keto-oxadiazole derivatives as cathepsin inhibitors | |
WO2002098850A3 (en) | Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors | |
WO2001081316A3 (en) | Substituted phenyl farnesyltransferase inhibitors | |
WO2002040455A8 (de) | Substituierte amidoalkyluracile und ihre verwendung als inhibitoren der poly (adp-ribose)-synthetase (pars) | |
IL161842A (en) | 2-amino-4-heteroarylethyl-thiazoline derivatives and pharmaceutical compositions comprising them | |
WO2003051838A3 (en) | Protein kinase inhibitors | |
WO2002014294A3 (en) | Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function | |
WO2002014275A3 (en) | Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function | |
WO2004048381A3 (en) | Pyrazoloazepine compounds as pharmaceutical agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
AK | Designated states |
Kind code of ref document: C1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2001994632 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2428335 Country of ref document: CA |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 2001994632 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10416622 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |